Advertisement
In an executive summary of a new guideline from the Society of Critical Care Medicine

Guidelines Detail Management of Liver Failure in ICU Patients

0
29 recommendations address CV, hematology, pulmonary, renal, endocrine considerations
Average employer-sponsored insurance spending rose to $5

2018 Health Care Spending Up Due to Higher Prices

0
2018 uptick in utilization first seen in years, but impact dwarfed by price increases
Expansion of National Comprehensive Cancer Network hereditary cancer testing criteria to include all women diagnosed with breast cancer at ≤65 years would improve the sensitivity of detection of germline pathogenic variants

Genetic Testing Proposed for All Women ≤65 With Breast Cancer

0
Expanded testing could increase detection of carriers for BRCA1/2, mutations in other predisposition genes
Colorectal cancer incidence and mortality are continuing to decline among adults aged 65 years and older but are increasing among younger adults

CRC Incidence, Mortality Declining for Adults Aged ≥65

0
However, incidence and CRC death rates increased for those aged younger than 50 years
Cancer risk awareness varies by socioeconomic status

Knowledge of Cancer Risk, Health Promotion Varies Widely

0
Gap by socioeconomic status seen in international survey
There are significant sex differences in salaries of clinical department chairs in public medical schools in the United States

Female Clinical Chairs Paid Significantly Less Than Men

0
Findings based on study of 550 clinical department chairs at 29 public U.S. medical schools
Omega-3 fatty acids do not appear to protect against cancer and may only have a small beneficial effect in coronary heart disease

Omega-3 Fatty Acids Seem Not to Protect Against Cancer

0
And, limited cardiovascular benefit found for long chain omega-3, alpha-linolenic acid
Almost half of young women with a breast cancer diagnosis experience financial decline

Many Young Women With Breast Cancer Experience Financial Decline

0
Common concerns among employed respondents include increased time off, suffering job performance
Receipt of molecularly matched therapy is associated with improved outcomes in patients with pancreatic cancer

Molecularly Matched Therapy Promising in Pancreatic Cancer

0
Overall survival significantly longer for patients with actionable molecular alterations receiving matched tx
Combined biopsy

Combined Biopsy Method Better for Prostate Cancer Diagnosis

0
Cancer diagnosed in 9.9 percent more, upgrading seen in 21.8 percent with MRI-targeted + systematic biopsy